Cyclic AMP responsive element binding protein phosphorylation and DNA binding is decreased by chronic lithium but not valproate treatment of SH- SY5Y neuroblastoma cells

Neuroscience

Volumn 91, Issue 2, 1999, Pages 771-776

  Wang, J F ^a   Asghari, V ^a   Rockel, C ^a   Young, L T ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Bipolar disorder; CREB; DNA binding; Lithium; Phosphorylation; Valproate

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA; FORSKOLIN; LITHIUM CHLORIDE; VALPROIC ACID;

AFFECTIVE NEUROSIS; ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DNA BINDING; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION REGULATION; MOOD; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; FORSKOLIN; HUMANS; KINETICS; LITHIUM CHLORIDE; NEUROBLASTOMA; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; VALPROIC ACID;

EID: 0032953393     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00627-7     Document Type: Article

References (34)

1. Avissar S., Schreiber G., Danon A., Balmaker R.H. Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature. 331:1988;440-442.
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analyt. Biochem. 72:1976;248-252.
3. Casebolt T.L., Jope R.S. Effects of chronic lithium treatment on protein kinase C and cyclic AMP-dependent protein phosphorylation. Biol. Psychiat. 29:1991;233-243.
4. Chen G., Pan B., Hawver D.B., Wright C.B., Potter W.Z., Manji H.K. Attenuation of cyclic AMP production by carbamazepine. J. Neurochem. 67:1996;2079-2086.
5. Chen G., Manji H.K., Wright C.B., Hawver D.B., Potter W.Z. Effects of valproic acid on beta-adrenergic receptors, G-proteins, and adenylyl cyclase in rat C6 glioma cells. Neuropsychopharmacology. 15:1996;271-280.
6. Chen G., Yuan P., Hawyer D.B., Potter W.Z., Manji H.K. Effects of valproic acid on beta-adrenergic receptors, G-proteins, and adenylyl cyclase in rat C6 glioma cells. Neuropsychopharmacology. 15:1997;272-280.
7. i-protein α subunit in rat cerebral cortex. Proc. natn. Acad. Sci. U.S.A. 88:1991;10,634-10,637.
8. Divish M.M., Sheftel G., Boyle A., Kalasapudi V.D., Papolos D.F. Differential effect of lithium on fos protooncogene expression mediated by receptor and postreceptor activators of protein kinase C and cyclic adenosine monophosphate: model for its antimanic action. J. Neurosci. Res. 28:1991;40-48.
9. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Archs gen. Psychiat. 54:1997;597-606.
10. Forn J., Valdecasas F.G. Effects of lithium on brain adenyl cyclase activity. Biochem. Pharmac. 20:1971;2773-2779.
11. Ginty D.D., Kornhauser J.M., Thompson M.A., Mayo I.C.E., Takahashi J.S., Greenberg M.E. Regulation of CREB phosphorylation in the suprachiasmatic nucleus by light and a circadian clock. Science. 260:1993;238-241.
12. Goldberg H., Clayman P., Skorecki K. Mechanism of Li inhibition of vasopressin-sensitive adenylate cyclase in cultured renal epithelial cells. Am. J. Physiol. 255:1988;F995-F1002.
13. Guitart X., Nestler E.J. Regulation of cylic AMP-dependent protein phosphorylation in rat frontal cortex by chronic lithium: identification of DARPP-32 and other lithium-regulated phosphoproteins. Soc. Neurosci. Abstr. 18:1992;104.
14. Jensen J.B., Mork A. Altered protein phosphorylation in the rat brain following chronic lithium and carbamazepine treatments. Eur. Neuropsychopharmac. 7:1997;173-179.
15. Jope R.S., Unlap T. Dexamethasone attenuates kainate-induced AP-1 activation in rat brain. Molec. Brain Res. 24:1994;275-282.
16. Kalasapudi V.D., Sheftel G., Divish M.M., Papolos D.F., Lachman H.M. Lithium augments fos protoonocogene expression in PC12 pheochromocytoma cells: implications for therapeutic action of lithium. Brain Res. 521:1990;47-54.
17. Leslie R.A., Moorman J.M., Grahame-Smith D.G. Lithium enhances 5-HT2A receptor-mediated c-fos expression in rat cerebral cortex. NeuroReport. 5:1993;241-244.
18. i-2 α-subunit mRNA levels in rat cortex. Molec. Pharmac. 206:1991;165-166.
19. Li P.P., Young L.T., Tam Y.K., Sibony D., Warsh J.J. Effects of chronic lithium and carbamazepine treatment on G protein subunit expression in rat cerebral cortex. Biol. Psychiat. 34:1993;167-170.
20. Li X., Jope R.S. Selective inhibition of the expression of signal transduction proteins by lithium in nerve growth factor-differentiated PC12 cells. J. Neurochem. 65:1995;2500-2508.
21. Manji H.K., Potter W.Z., Lenox R.H. Molecular targets for lithium's actions. Archs gen. Psychiat. 52:1995;531-543.
22. Manji H.K., Chen G., Shimon H., Hsiao J.K., Potter W.Z., Belmaker R.H. Guanine nucleotide-binding proteins in bipolar affective disorder. Archs gen. Psychiat. 52:1995;135-144.
23. Miller J.C., Mathe A.A. Basal and stimulated C-fos mRNA expression in the rat brain: effect of chronic dietary lithium. Neuropsychopharmacology. 16:1997;408-418.
24. Nibuya M., Morinobu S., Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 15:1995;7539-7547.
25. Nibuya M., Nestler E.J., Duman R.S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci. 16:1996;2365-2372.
26. Ozaki N., Chuang D.M. Lithium increases transcription factor binding to AP-1 and cyclic AMP-responsive element in cultured neurons and rat brain. J. Neurochem. 69:1997;2336-2344.
27. Perez J., Zanardi R., Mori S., Gasperini M., Smeraldi E., Racagni G. Abnormalities of cAMP-dependent endogenous phosphorylation in platelets from patients with bipolar disorder. Am. J. Psychiat. 152:1995;1204-1206.
28. 3H cAMP binding in postmortem brain from subjects with bipolar affective disorder. J. Neurochem. 68:1996;297-304.
29. Wang J.F., Young L.T. Differential display PCR reveals increased expression of 2′,3′-cyclic nucleotide 3′-phosphodiesterase by lithium. Fedn Eur. biochem. Socs Lett. 386:1996;225-229.
30. Wang J. F., Li P. P., Warsh J. J. and Young L. T. (1997) Signal transduction abnormalities in bipolar disorder. In Bipolar Disorder: Biological Methods and Their Clinical Application (eds Young L. T. and Joffe R. T.), pp. 41-79. Marcel Dekker, New York.
31. Williams M.B., Jope R.S. Distinctive rat brain immediate early gene responses to seiqures induced by lithium plus pilocarpine. Molec. Brain Res. 25:1994;80-89.
32. sα protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder. J. Neurochem. 61:1991;890-898.
33. Young L.T., Li P.P., Kamble A., Siu K.P., Warsh J.J. Mononuclear leukocyte levels of G-proteins in depressed patients with bipolar disorder or major depressive disorder. Am. J. Psychiat. 151:1994;594-596.
34. Zanardi R., Racagni G., Smeraldi E., Perez J. Differential effects of lithium on platelet protein phosphorylation in bipolar patients and healthy subjects. Psychopharmacology. 129:1997;44-47.